Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells
- 8 August 2014
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 11 (1) , 99-108
- https://doi.org/10.1016/j.nano.2014.07.013
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Vaccine-Elicited CD8 + T Cells Protect against Respiratory Syncytial Virus Strain A2-Line19F-Induced Pathogenesis in BALB/c MiceJournal of Virology, 2012
- Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in MiceThe Journal of Infectious Diseases, 2011
- Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G ProteinsJournal of Virology, 2011
- Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particlesVirology, 2010
- Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of ImmunopathologyJournal of Virology, 2010
- Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse SkinPLOS ONE, 2009
- Influenza vaccines based on virus-like particlesVirus Research, 2009
- Differential Role of Gamma Interferon in Inhibiting Pulmonary Eosinophilia and Exacerbating Systemic Disease in Fusion Protein-Immunized Mice Undergoing Challenge Infection with Respiratory Syncytial VirusJournal of Virology, 2008
- Viral and Host Factors in Human Respiratory Syncytial Virus PathogenesisJournal of Virology, 2008
- Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometryJournal of Immunological Methods, 2007